Author

Xiaoling Zhu

Observed name: X. Zhu

Institution: Dali University

Observed institutions: Central South University, Yunnan University, Third Xiangya Hospital, Dali University

ORCID: 0000-0002-8155-6494

Observed ORCID: 0000-0002-8155-6494

OpenAlex ID: A5015683290

Bilirubin nanoparticles modulate Treg/Th17 cells and functional metabolism of gut microbiota to inhibit lung adenocarcinoma

2024 · Xiaoling Zhu, Wenxiang Tang, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 10

G2 and S phase-expressed protein 1 is a biomarker for poor prognosis in lung adenocarcinoma

2024 · Xitong Yang, Xiaoling Zhu · Medicine · 5

DEP domain containing 1 as a biomarker for poor prognosis in lung adenocarcinoma

2024 · Cuixian Li, Xiaoling Zhu · Heliyon · 2

The expression of tyrosine kinase and threonine promotes the progression of lung adenocarcinoma and is linked to a negative prognosis

2026 · Xiaoling Zhu, Shengdan Li, et al. · Medicine · 1

[Association between dietary habits and Helicobacter pylori infection in elderly health examination population in Hunan province].

2025 · Pingping Yan, Guanxiu Tang, et al. · PubMed Central

Linkage of cell division cycle 42 with clinical features, treatment response and survival in adult Philadelphia chromosome negative acute lymphoblastic leukemia

2024 · Qi Chen, Xiaoling Zhu, et al. · Scandinavian Journal of Clinical and Laboratory Investigation

104P NTRK3 mutation affects the efficacy of immune checkpoint inhibitors in patients with advanced cancer

2022 · H. Tian, Y. Qi, et al. · Annals of Oncology

Works count: 7

Citation count: 18

H-index: 2

I10-index: 1